会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • MATERIALS AND METHODS FOR PREVENTING AND TREATING MICROBE-MEDIATED EPITHELIAL DISORDERS
    • 预防和治疗微血管介导的上皮疾病的材料与方法
    • WO2004047778A1
    • 2004-06-10
    • PCT/US2002/037948
    • 2002-11-26
    • UC TECHALVERDY, John, C., M.D.
    • ALVERDY, John, C., M.D.
    • A61K7/06
    • A61K31/765A23K20/105A23K50/10A23K50/20A23K50/30A23K50/40A23K50/75A23L33/10A23L33/40A61K31/198A61K31/721A61K31/77A61K2300/00
    • The present invention provides pharmaceutical compositions in the form of relatively high molecular weight biocompatible polymers such as polyethylene glycol, optionally supplemented with a protective polymer such ad dextran and/or essential pathogen nutrients such as L-glutamine. Also provided are methods for preventing or treating gut-derived sepsis attributable to intestinal pathogens such as Pseudomonas aeruginosa by administering high molecular weight polyethylene glycol as well as methods for monitoring the administration of high molecular weight polyethylene glycol, such as in methods of preventing, ameliorating or treating microbe-induced epithelial disorders, as exemplified by gut-derived sepsis. Frequently, gut-derived sepsis arises as a complication in mammals recovering from surgical intervention or suffering from a disease or disorder, providing indications of suitable animals to receive preventative treatment. Finally, the invention provides a composition comprising infant formula and polyethylene glycol and methods for using that composition.
    • 本发明提供了具有相对高分子量的生物相容性聚合物形式的药物组合物,例如聚乙二醇,任选地补充保护性聚合物如葡聚糖和/或必需的病原体营养物如L-谷氨酰胺。 还提供了通过施用高分子量聚乙二醇来预防或治疗归因于肠道病原体如铜绿假单胞菌的肠源性败血症的方法以及用于监测高分子量聚乙二醇的施用的方法,例如在预防,改善 或治疗微生物诱导的上皮疾病,例如肠源性败血症。 通常,肠道衍生的败血症是由外科手术或患有疾病或病症而恢复的哺乳动物的并发症,提供合适动物接受预防治疗的适应症。 最后,本发明提供包含婴儿配方和聚乙二醇的组合物和使用该组合物的方法。
    • 2. 发明申请
    • Computerized scheme for distinction between benign and malignant nodules in thoracic low-dose CT
    • 用于区分胸部低剂量CT的良性和恶性结节的计算机化方案
    • US20060018524A1
    • 2006-01-26
    • US11181884
    • 2005-07-15
    • Kenji SuzukiKunio Doi
    • Kenji SuzukiKunio Doi
    • G06K9/00
    • G06K9/3233G06K9/6292G06K2209/05G06T7/0012G06T2207/30061
    • A system, method, and computer program product for classifying a target structure in an image into abnormality types. The system has a scanning mechanism that scans a local window across sub-regions of the target structure by moving the local window across the image to obtain sub-region pixel sets. A mechanism inputs the sub-region pixel sets into a classifier to provide output pixel values based on the sub-region pixel sets, each output pixel value representing a likelihood that respective image pixels have a predetermined abnormality, the output pixel values collectively determining a likelihood distribution output image map. A mechanism scores the likelihood distribution map to classify the target structure into abnormality types. The classifier can be, e.g., a single-output or multiple-output massive training artificial neural network (MTANN).
    • 一种用于将图像中的目标结构分类为异常类型的系统,方法和计算机程序产品。 该系统具有扫描机构,通过移动该图像上的局部窗口来扫描目标结构的子区域上的局部窗口,以获得子区域像素集。 机构将子区域像素集合输入到分类器中以基于子区域像素集提供输出像素值,每个输出像素值表示各个图像像素具有预定异常的可能性,输出像素值共同确定似然 分布输出图像映射。 一种机制评估了可能性分布图,将目标结构分类为异常类型。 分类器可以是例如单输出或多输出大规模训练人造神经网络(MTANN)。
    • 6. 发明专利
    • BR0215954A
    • 2005-09-13
    • BR0215954
    • 2002-11-26
    • UC TECH
    • ALVERDY JOHN C M D
    • A23K1/16A23K1/18A23L1/30A23L33/00A61K31/765A61K39/108A61K47/34A61K7/06
    • The present invention provides pharmaceutical compositions in the form of relatively high molecular weight biocompatible polymers such as polyethylene glycol, optionally supplemented with a protective polymer such as dextran and/or essential pathogen nutrients such as L-glutamine. Also provided are methods for preventing or treating gut-derived sepsis attributable to intestinal pathogens such as Pseudomonas aeruginosa by administering high molecular weight polyethylene glycol as well as methods for monitoring the administration of high molecular weight polyethylene glycol, such as in methods of preventing, ameliorating or treating microbe-induced epithelial disorders, as exemplified by gut-derived sepsis. Frequently, gut-derived sepsis arises as a complication in mammals recovering from surgical intervention or suffering from a disease or disorder, providing indications of suitable animals to receive preventative treatment. Finally, the invention provides a composition comprising infant formula and polyethylene glycol and methods for using that composition.